Archive
Share

HPV vaccine blinds 16-year-old girl

By VT / June 25, 2010

David Gutierrez NaturalNews.com 06/24/2010 A 16-year-old girl lost nearly all of her vision within 10 days of receiving the second course of her vaccine against the human papilloma virus (HPV), reports a case study in the Journal of Child Neurology. The HPV vaccine is designed to prevent infection by the strains of the virus that […]

Share

Vaccines Derived from Patients’ Tumor Cells Are Individualizing Cancer Treatment

By VT / June 25, 2010

Erica Rex Scientific American 06/24/2010 The first discovery of a cancer gene marker—the BRAF oncogene for melanoma and colorectal malignancies—back in 2002 changed the way many researchers thought about cancer treatment. Rather than approach the disease based on what region of the body it stemmed from, scientists began to identify cancers in terms of their […]

Share

Many in Fort Collins rush to get meningitis vaccines in wake of deaths

By VT / June 24, 2010

After Lisa Krizman of Loveland lost her daughter, Sierra, to meningitis in 2007, she started a foundation to bolster awareness of the disease and raise money for vaccination clinics. Now that Fort Collins Adult Hockey Association players Brian Wormus and Nick Smith have died of invasive meningococcal disease, Krizman is fast-tracking a meningitis vaccination clinic […]

Share

Measles Virus-induced Immunosuppression

By VT / June 23, 2010

Excerpt from Polymicrobial Diseases Chapter 19 – Virus-induced Immunosuppression http://www.ncbi.nlm.nih.gov “MV infection produces an immune system paradox. MV infection, while inducing lifelong immunity, also suppresses the immune system leading to an increase in susceptibility to other, secondary infections (24, 67, 91). In vitro research has shown that MV infection of cell cultures makes the cells […]

Share

Merck wants your Tired, your Poor to be ‘One Less’ Gardasil Access Program Targets Third World Countries

By VT / June 23, 2010

SEO Press Releases 06/23/2010 Vaccine Adverse Reporting System (VAERS) May statistics on HPV vaccine injury and death now stands at 18,445 adverse reaction (increase of 1,000 in the last 6 weeks), 75 deaths, 3,771 not recovered, 4,905 unknown recovered, 610 disabled, 355 life threatening, 7,858 ER visits, 1,865 hospitalized. The numbers reflect only 1 to […]

Share

UPDATE 2-Merck KGaA resumes vaccine trials in lung cancer

By VT / June 23, 2010

Ludwig Burger Reuters 06/23/2010 FRANKFURT, June 17 (Reuters) – Germany’s Merck KGaA (MRCG.DE) and its U.S. partner Oncothyreon (ONTY.O) have resumed testing their experimental cancer vaccine Stimuvax on lung-cancer patients, reviving hopes for a key pipeline drug. The U.S. Food and Drug Administration (FDA) lifted the hold it had placed on a Phase III trial […]

Share

Nobel laureate scientist defines future vaccines as “food”

By VT / June 22, 2010

Xiong Tong xinhuanet.com 06/21/2010 Barry J. Marshall, Nobel Laureate in Physiology or Medicine 2005 and clinical professor with the University of Western Australia, said people might, in the future, be vaccinated by swallowing capsules instead of by using needles. He made his remarks at the World Expo’s third theme forum, which opened on Sunday in […]

Share

Why your child’s meningitis jab may NOT offer protection after all

By VT / June 22, 2010

Rachel Ellis Daily Mail 06/22/2010 Parents have their children vaccinated in the belief it offers vital protection against serious infections. But now there are concerns that the meningitis C vaccine may not be effective during key times in their child’s life. New research has revealed that within seven years of receiving the jab, three quarters […]

Share

‘One size fits all’ allergy jab for hay fever, asthma and eczema on the way

By VT / June 22, 2010

By Andrew Hough Telegraph.co.uk 06/22/2010 Swiss researchers claimed allergies that blight the lives of 10 million British sufferers could be largely eradicated with a single vaccine. An allergy conference in London heard the “one size fits all” injection that wards off asthma, eczema, hay fever and even peanut allergies could be on the shelves within […]

Share

Europe’s drugmakers beat U.S. on access for poor

By VT / June 21, 2010

Kate Kelland Reuters 06/20/2010 The Access to Medicines Index (AMI) — released this week for the second time since its launch in 2008 — is produced by a Dutch-based foundation and backed by 22 institutional investors and fund managers, who together manage $3.1 trillion in assets. It put Britain’s GlaxoSmithKline at the top of its […]

Share

PCBs May Weaken Kids’ Vaccination Response

By VT / June 21, 2010

Robert Preidt Bloomberg Businessweek 06/20/2010 Children exposed early in life to polychlorinated biphenyls (PCBs) may have a reduced immune response to tetanus and diphtheria vaccines, a new study indicates. The findings suggest that exposure to the environmental pollutants in the first years of life (a critical time in immune system development) could undermine the effectiveness […]

Share

FDA Gardasil Decision Delayed

By VT / June 21, 2010

NewsInferno 06/17/2010 The Food & Drug Administration (FDA) has put off a decision on whether or not it should approve the expanded use of the Gardasil vaccine to older women, ages 27 to 45. The FDA’s decision, which was expected sometime next week, will not come until later this year. Approved in 2006, Gardasil prevents […]

Share

Immediate Action to Prevent Cervical Cancer Deaths Key to Achieving Women’s Health Goals Trial and Error: Ethical Violations of HPV Vaccination Trials in India

By VT / June 21, 2010

SEO Press Releases 06/21/2010 Within the last month reports from two women’s organizations focused global attention on the silent epidemic of sexually transmitted diseases (STD’s) and their plans to provide accessibility to care. On June 8, health leaders at the WOMEN DELIVER conference in Washington D.C. called on the international community to commit resources to […]